Ownership

Kyle Gano - Chief Executive Officer, Director at Neurocrine Biosciences Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: NBIX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Kyle Gano - trading volume in the past year for Neurocrine Biosciences Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-80.5K	100%	$131.92	-$10.6M
Net	-80.5K	-100%		-$10.6M

Holdings reported by Kyle Gano for Neurocrine Biosciences Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	135K	$18M	$132.89	Feb 13, 2024	Direct
Restricted Stock Unit	8.97K	$1.19M	$133.03	Feb 13, 2024	Direct	Common Stock
Stock Option	45.1K			Feb 13, 2024	Direct	Common Stock
Stock Option	13.3K			Nov 1, 2024	Direct	Common Stock
Restricted Stock Unit	2.46K			Nov 1, 2024	Direct	Common Stock
Incentive Stock Option	0		$19.59	Jan 2, 2024	Direct	Common Stock
Non-Qualified Stock Option	0		$79.02	Jan 2, 2024	Direct	Common Stock

Transactions reported by Kyle Gano for Neurocrine Biosciences Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.